Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alpha Cognition Inc.

< Previous 1 2 3 Next >
News headline image
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
News headline image
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences
From Alpha Cognition Inc.
Via Business Wire
Tickers ACOG
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.